Theraclion S.A.
TCLIF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$43.39M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $43.39 Million |
|---|---|
| Enterprise Value | $47.31 Million |
| Earnings per Share | $-0.09 |
| Beta | 0.45 |
| Outstanding Shares | 73,096,812 |
Return
| Return on Equity | 3213.58% |
|---|---|
| Return on Assets | -85.87% |
| Return on Invested Capital | -125.89% |
Valuation & Multiples
| P/E Ratio | -5.68 |
|---|---|
| PEG | -14.13 |
| Price to Sales | - |
| Price to Book Ratio | -0.53 |
| Enterprise Value to Revenue | 15.65 |
| Enterprise Value to EBIT | -3.56 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | -12.52 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 16, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 29, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Theraclion S.A.
36 employees
CEO: Martin Deterre
Theraclion SA, established in 2004 and based in Malakoff, France, specializes in developing innovative echotherapy medical solutions. These treatments harness high-intensity focused ultrasound (HIFU) technology. Their offerings include S...